Deep Track Capital, LP - Significant Ownership

Signature - Title: /s/ David Kroin - David Kroin, Managing Member of the General Partner of the Investment Adviser
Location: Greenwich, CT
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Deep Track Capital, LP.

Significant Ownership of Deep Track Capital, LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
DVAX	Dynavax Technologies Corporation	Common Stock, par value $0.001 per share	13.5%	$194M		17.8M		Deep Track Biotechnology Master Fund, Ltd.	Feb 18, 2025
CMPS	COMPASS Pathways plc	American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share	9.99%	$35M		9.27M		Deep Track Capital, LP	Jan 10, 2025
RAPT	RAPT Therapeutics, Inc.	Common Stock $0.0001 par value per share	9.87%	$12.3M		14.1M		Deep Track Capital, LP	Dec 23, 2024
OCUL	OCULAR THERAPEUTIX, INC	Common Stock, $0.0001 par value per share	9.65%	$122M		15.5M		Deep Track Capital, LP	Mar 31, 2025
ETNB	89bio, Inc.	Common stock, par value $0.001 per share	9.18%	$95.3M	$50.6M	13.8M	+113%	Deep Track Capital, LP	Mar 31, 2025
ENGN	enGene Holdings Inc.	Common Shares	8.94%	$18.2M		4.56M		Deep Track Capital, LP	Dec 31, 2024
CNTX	Context Therapeutics Inc.	Common Stock, $0.001 par value per share	8.27%	$7.42M		7.42M		Deep Track Capital, LP	Mar 31, 2025
MNMD	Mind Medicine (MindMed) Inc.	Common Shares	8.19%	$41M		6.5M		Deep Track Capital, LP	Mar 31, 2025
IVVD	Invivyd, Inc.	Common stock, par value $0.0001 per share	8.1%	$6.42M		9.72M		Deep Track Capital, LP	Mar 31, 2025
ALLK	Allakos Inc.	Common Stock, par value $0.001	8.02%	$2.31M		7.23M		Deep Track Capital, LP	Mar 31, 2025
TECX	Tectonic Therapeutic Inc.	Common Stock $0.001 par value per share	7.6%	$31.4M		1.4M		Deep Track Capital, LP	Feb 3, 2025
DNTH	Dianthus Therapeutics Inc.	Common Stock, $0.001 Par Value	7.34%	$51.3M		2.36M		Deep Track Capital, LP	Mar 17, 2025
NRIX	Nurix Therapeutics, Inc.	Common Stock, par value $0.001 per share	7.21%	$63.6M	$15.9M	5.5M	+33.3%	Deep Track Capital, LP	Mar 31, 2025
GPCR	Structure Therapeutics Inc.	Ordinary Shares, $0.0001 par value	7.15%	$319M	$85.5M	12.3M	+36.7%	Deep Track Capital, LP	Mar 31, 2025
MAZE	Maze Therapeutics Inc.	Common Stock, $0.001 par value per share	6.91%	$26.6M		3.02M		Deep Track Capital, LP	Jan 31, 2025
TERN	Terns Pharmaceuticals, Inc.	Common Stock, $0.0001 par value per share	6.39%	$16.3M		5.58M		Deep Track Capital, LP	Mar 31, 2025
BCYC	Bicycle Therapeutics plc	American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share	5.67%	$23.2M	-$4.18M	2.82M	-15.3%	Deep Track Capital, LP	Mar 31, 2025
IMVT	Immunovant Inc.	Common Stock, $0.0001 par value per share	5.59%	$145M		9.5M		Deep Track Capital, LP	Mar 19, 2025
APLS	Apellis Pharmaceuticals, Inc.	Common Stock, $0.0001 par value per share	5.57%	$126M		7M		Deep Track Capital, LP	May 9, 2025
GERN	Geron Corp	Common Stock, $0.001 par value	5.5%	$48.3M		35M		Deep Track Capital, LP	Mar 18, 2025
PTGX	PROTAGONIST THERAPEUTICS, INC.	Common Stock, par value $0.00001	5.29%	$145M		3.25M		Deep Track Capital, LP	Apr 3, 2025
IKNA	Ikena Oncology, Inc.	Common Stock, $0.001 par value	5.21%	$2.67M		2.52M		Deep Track Capital, LP	Feb 7, 2025
ORKA	Oruka Therapeutics, Inc.	Common Stock, par value $0.001 per share	5.07%	$19.9M		1.9M		Deep Track Capital, LP	May 6, 2025
OLMA	Olema Pharmaceuticals, Inc.	Common Stock, par value $0.0001 per share	5.04%	$17.4M		3.44M		Deep Track Capital, LP	Mar 31, 2025
SWTX	Springworks Therapeutics, Inc.	Common Stock, par value $0.0001 per share	4.65%	$160M		3.46M		Deep Track Capital, LP	Dec 31, 2024
GH	Guardant Health, Inc.	Common Stock, $0.00001 Par Value	4.41%	$270M		5.44M		Deep Track Capital, LP	Mar 31, 2025
OKUR	Onkure Therapeutics, Inc.	Common Stock, par value $0.0001 per share	4.14%	$1.33M		524K		Deep Track Capital, LP	Dec 31, 2024
FDMT	4D Molecular Therapeutics Inc.	Common Stock, par value $0.0001 per share	1.32%	$1.98M		610K		Deep Track Capital, LP	Dec 31, 2024
NKTR	Nektar Therapeutics	Common Stock, par value $0.0001	1.07%	$1.46M		1.98M		Deep Track Capital, LP	Dec 31, 2024
SYRS	Syros Pharmaceuticals, Inc.	Common Stock, $0.001 par value	0%	$0		0		Deep Track Capital, LP	Dec 31, 2024
PYXS	Pyxis Oncology, Inc.	Common Stock, par value $0.001 per share	0%	$0		0		Deep Track Capital, LP	Dec 31, 2024
EDIT	Editas Medicine, Inc.	Common Stock, $0.0001 par value per share	0%	$0		0		Deep Track Capital, LP	Dec 31, 2024

Previous1Next

Showing 1 to 32 of 32 entries

Schedules 13D/G Reported by Deep Track Capital, LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
Loading...

PreviousNext

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.